secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arch Therapeutics, Inc. (—)
CIK:        0001537561
Form:       8-K
Filed at:   2025-02-07T23:59:59+00:00
Accession:  0001493152-25-005383
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Arch Therapeutics CFO Abrams resigns; CEO Norchi assumes additional officer roles
--------------------------------------------------------------------------------

- Michael S. Abrams resigned as CFO and Treasurer effective Feb 3, 2025, and waived contract claims.
- CEO Terrence W. Norchi appointed Principal Accounting Officer and Treasurer same day.
- Norchi continues as CEO, Chairman, President, and Secretary of the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1537561/000149315225005383/0001493152-25-005383-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1537561/000149315225005383/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-005383

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer